Trial Profile
To protect peripheral oxaliplatin-related neuralgia by pregabalin in Kansai area
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Acronyms HARUKA study
- 16 May 2016 New trial record